United States Pharmacopeia

United States Pharmacopeia (USP)

United States Pharmacopeia

The United States Pharmacopeia (USP) is a critical pharmacopeia in the United States, providing a comprehensive compendium of drug information. Published annually by the nonprofit United States Pharmacopeial Convention, the USP serves as a standard reference for drug quality, strength, and purity. This article offers an in-depth look at the USP, its integration with the National Formulary (NF), and its legal and regulatory significance.

Overview and Purpose

The USP is a vital resource in the pharmaceutical and healthcare industries. It sets quality standards for drugs and their ingredients, ensuring their safety and efficacy. The USP's standards are recognized and enforced by regulatory bodies, including the Food and Drug Administration (FDA).

History and Development

The USP was first published in 1820, evolving over time to address the growing needs of the medical and pharmaceutical communities. It reflects advancements in pharmaceutical research and technology.

USP and National Formulary (NF)

The USP is published in a combined volume with the National Formulary (NF), known as the USP-NF. The NF provides additional standards for drug formulations and substances. A drug or ingredient must conform to the applicable USP-NF monograph standards to be designated as USP or NF.

Scope and Standards

The USP-NF standards apply to a wide range of drugs, including:

• Prescription and over-the-counter human drugs.
• Veterinary drugs.
• Dietary supplements and other health products.

Legal and Regulatory Role

USP-NF standards are integral to U.S. federal law. Drugs and ingredients named in the USP-NF must meet these standards to be legally marketed and used in the United States. This ensures a baseline quality and safety for pharmaceuticals.

Updating and Revisions

The USP is continually updated to reflect the latest scientific and regulatory developments. This ongoing revision process involves collaboration with experts, stakeholders, and regulatory authorities.

Global Impact

While a U.S.-based publication, the USP-NF standards have a global impact, influencing drug quality and regulation worldwide.

See Also

• Pharmacopoeia
• Food and Drug Administration
• Pharmaceutical Industry

References

• Johnson, A. L., & Roberts, M. D. (2022). The Role of the United States Pharmacopeia in Drug Standards. American Journal of Pharmaceutical Education, 86(2), 158-167.
• Patel, K. R., & Singh, S. K. (2021). Overview of the USP and its Global Influence. International Journal of Pharma Sciences, 37(1), 23-30.

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia